Panakes Partners is a Venture Capital investor that finances medical companies, early stage startup and SMEs, with extremely promising products and great ambition, in Europe and Israel. Thanks to our strong entrepreneurial and financial experiences we provide more than capital, and we aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor. We also have strong relationship with selected industrial partners to help companies to accelerate their development. Panakes derives from Panacea (Greek Πανάκεια, Panakeia), who was the goddess of Universal remedy, said to have a potion with which she healed the sick.
27
Total Investments
19
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Biotechnology, Finance +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Panakes Partners
Recent Investments (27)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | May 2025 | |
| Series B | •••••• | Sep 2024 | |
| Series C | •••••• | Feb 2024 | |
| Series B | •••••• | Jan 2024 | |
| Seed Round | •••••• | Jan 2024 | |
|
|
Series C | •••••• | Nov 2023 |
|
|
Series B | •••••• | Jul 2023 |
|
|
Series A | •••••• | Jun 2023 |
|
|
Series B | •••••• | Jun 2023 |
|
|
Series A | •••••• | Apr 2023 |
Latest News
Novo Nordisk’s owner backs an Italian fund to grow drug startups beyond Denmark
Thenextweb · Jul 02, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.